Vicarious inks software partnership as it streamlines operations

Group 1 - Vicarious is developing a single-port robotic system aimed at abdominal procedures, targeting a significant market where 82% of over 5.6 million annual U.S. abdominal surgeries are still performed as open or laparoscopic surgeries [3] - The company has postponed the initiation of a clinical trial to focus on completing the design of its commercial robotic system, with a previous target for FDA submission set for late 2026 [4] - Vicarious has partnered with a digital engineering and software development firm to enhance operational efficiency, reduce costs, and improve development predictability [7] Group 2 - The partnership is expected to allow Vicarious to concentrate on core innovation and system integration while the partner handles engineering functions [7] - The company has reduced its cash burn forecast for 2025 by $5 million to approximately $45 million, with a projected cash burn of about $35 million for 2026 [5] - Vicarious estimates it will need an additional $25 million beyond existing resources to finalize the design of its robotic system [5]